Monday Morning Rounds with CMS

ICYMI, here is recent communication from CMS.




Inflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
CMS announced the list of 34 prescription drugs for which Part B beneficiary coinsurances may be lower between October 1 – December 31, 2023. Some people with Medicare who take these drugs may save between $1 and $618 per average dose starting October 1, 2023, depending on their individual coverage. Through the Inflation Reduction Act, President Biden and his Administration are lowering prescription drug costs for millions of American seniors and their families.

CMS Issues Fact Sheet on the Process for the Medicare Drug Price Negotiation Program
CMS issued a fact sheet with key information on the process for the first round of negotiations for the Medicare Drug Pricing Negotiation Program, following the Historic Announcement of the First Selected Drugs for Medicare Drug Price Negotiation.


Reminder: 2023 MIPS Value Pathway (MVP) Registration is Open
The Merit-based Incentive Payment System (MIPS) Value Pathways (MVPs) registration window is open for the 2023 performance year. Individuals, groups, subgroups, and Alternative Payment Model (APM) Entities that wish to report an MVP can register until November 30, 2023, at 8 p.m. ET. For the 2023 performance year, MVPs are a new, voluntary way to meet MIPS reporting requirements. Each MVP includes a subset of measures and activities that are related to a specialty or medical condition to offer more meaningful participation in MIPS.

Quality Payment Program

Administrative Simplification

CMS Innovation Center